Stock 600513 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Equities

600513

CNE000001DP6

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 25/06/2024 BST 		5-day change 1st Jan Change
8.21 CNY +3.01% Intraday chart for Jiangsu Lianhuan Pharmaceutical Co., Ltd. 0.00% -26.30%
08:47am Lianhuan Pharmaceutical's Moxifloxacin Hydrochloride Tablets Get Drug Registration Certificate MT
06-20 China Grants Active Pharmaceutical Ingredient Marketing Approval for Lianhuan Pharma's Cardiac Treatment MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lianhuan Pharmaceutical's Moxifloxacin Hydrochloride Tablets Get Drug Registration Certificate
MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Lianhuan Pharma Obtains China Registration Approval for Antihistamine
MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Lianhuan Pharma's Production Lines Pass GMP Inspection
MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jiangsu Lianhuan Pharma Plans Listing Unit on ‘New Third Board’
MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Lianhuan Pharma Gets Nod for Erectile Dysfunction Drug
MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Jiangsu Lianhuan Pharmaceutical Gets Nod to Market Antihistamine Ingredient in China
MT
Lianhuan Pharma Gets Nod for Anti-Allergy Drug Registration
MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600513 Stock
  4. News Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  5. Highlights